Use of Standardized SCID-hu Thy/Liv Mouse Model for Preclinical Efficacy Testing of Anti-Human Immunodeficiency Virus Type 1 Compounds.

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.40.3.755
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Coinfection of SCID-hu Thy/Liv Mice With Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Potent Activity of the HIV-1 Maturation Inhibitor Bevirimat in SCID-hu Thy/Liv Mice

PLoS ONE
Multidisciplinary
2007English

New Methods in Virology. Model of Viral Infection in SCID Mice: SCID-hu Mouse and Hu-PBL-Scid Mouse.

Uirusu. Journal of virology
Medicine
1999English

Evaluation of Dried Blood Spots for Human Immunodeficiency Virus Type 1 Drug Resistance Testing

Journal of Clinical Microbiology
Microbiology
2006English

Genotypic Antiretroviral Resistance Testing for Human Immunodeficiency Virus Type 1 Integrase Inhibitors by Use of the TruGene Sequencing System

Journal of Clinical Microbiology
Microbiology
2008English

Organization of Immature Human Immunodeficiency Virus Type 1

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2001English

Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model

Frontiers in Immunology
AllergyImmunology
2017English

Comparative Analysis of Two Commercial Phenotypic Assays for Drug Susceptibility Testing of Human Immunodeficiency Virus Type 1

Journal of Clinical Microbiology
Microbiology
2002English

Use of Rapid and Conventional Testing Technologies for Human Immunodeficiency Virus Type 1 Serologic Screening in a Rural Kenyan Reference Laboratory

Journal of Clinical Microbiology
Microbiology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy